Weekly IcoSema Matches Daily Insulin Therapy in T2D ...Middle East

News by : (Medscape) -
Once-weekly IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Weekly IcoSema Matches Daily Insulin Therapy in T2D )

Also on site :

Most Viewed News
جديد الاخبار